Clinical trials
Completed trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4,979 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 19 |
| 2001 | 30 |
| 2002 | 58 |
| 2003 | 66 |
| 2004 | 95 |
| 2005 | 140 |
| 2006 | 202 |
| 2007 | 197 |
| 2008 | 262 |
| 2009 | 268 |
| 2010 | 276 |
| 2011 | 259 |
| 2012 | 265 |
| 2013 | 296 |
| 2014 | 287 |
| 2015 | 278 |
| 2016 | 266 |
| 2017 | 295 |
| 2018 | 311 |
| 2019 | 247 |
| 2020 | 262 |
| 2021 | 197 |
| 2022 | 138 |
| 2023 | 108 |
| 2024 | 62 |
| 2025 | 21 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4,979 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hadassah Medical Organization | 182 |
| Sheba Medical Center | 170 |
| Rambam Health Care Campus | 160 |
| Novartis Pharmaceuticals | 156 |
| Hoffmann-La Roche | 138 |
| Meir Medical Center | 124 |
| Bayer | 117 |
| HaEmek Medical Center, Israel | 108 |
| Rabin Medical Center | 106 |
| Novo Nordisk A/S | 96 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 154 |
| Breast Neoplasms | 118 |
| Diabetes Mellitus | 114 |
| Crohn Disease | 87 |
| Neoplasms | 86 |
| Diabetes Mellitus, Type 1 | 83 |
| Colitis, Ulcerative | 79 |
| Carcinoma, Non-Small-Cell Lung | 77 |
| Heart Failure | 74 |
| Pain | 68 |
Trials
Showing 1 to 25 of 4,979. Each trial links to its page on Pharma Observatory.
4,879 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.